Regent Investment Management’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
$230K Buy
+1,800
New +$209K 0.06% 193
2022
Q2
Sell
-1,800
Closed -$230K 211
2022
Q1
$230K Sell
1,800
-54
-3% -$6.51K 0.05% 196
2021
Q4
$229K Hold
1,854
0.05% 201
2021
Q3
$263K Hold
1,854
0.06% 188
2021
Q2
$289K Hold
1,854
0.07% 182
2021
Q1
$288K Hold
1,854
0.07% 173
2020
Q4
$277K Hold
1,854
0.08% 168
2020
Q3
$245K Hold
1,854
0.08% 164
2020
Q2
$215K Buy
+1,854
New +$214K 0.07% 171
2020
Q1
Sell
-1,854
Closed -$269K 210
2019
Q4
$269K Hold
1,854
0.08% 175
2019
Q3
$247K Hold
1,854
0.08% 180
2019
Q2
$212K Hold
1,854
0.07% 191
2019
Q1
$230K Buy
+1,854
New +$211K 0.08% 187
2018
Q4
Sell
-1,854
Closed -$237K 207
2018
Q3
$237K Hold
1,854
0.07% 185
2018
Q2
$201K Buy
+1,854
New +$202K 0.07% 194
2018
Q1
Sell
-1,854
Closed -$217K 214
2017
Q4
$217K Hold
1,854
0.07% 195
2017
Q3
$211K Hold
1,854
0.07% 197
2017
Q2
$231K Hold
1,854
0.08% 190
2017
Q1
$220K Sell
1,854
-206
-10% -$23.3K 0.08% 188
2016
Q4
$206K Buy
2,060
+206
+11% +$22.1K 0.11% 173
2016
Q3
$234K Hold
1,854
0.12% 162
2016
Q2
$217K Buy
+1,854
New +$210K 0.12% 168

Other funds holding ZBH

Regent Investment Management's ZBH Position: Q4 2022 in Review

Regent Investment Management opened a new position in Zimmer Biomet (ZBH) in Q4 2022: 1,800 shares worth $230K. The stake represents 0.06% of the portfolio and ranks #193 among its holdings. This is a return to the name: Regent Investment Management previously reported a position in ZBH as recently as Q1 2022.

Regent Investment Management first reported a position in ZBH in Q2 2016 and has held it in 22 quarters since. The position peaked at $289K in Q2 2021. 977 funds tracked by Wall St. Rank hold ZBH as of Q4 2022.

  • Regent Investment Management held 1,800 shares of Zimmer Biomet worth $230K as of Q4 2022.
  • Zimmer Biomet was a new Regent Investment Management position in Q4 2022.
  • Zimmer Biomet made up 0.06% of Regent Investment Management's portfolio in Q4 2022, its #193 holding.
  • Regent Investment Management first reported a position in Zimmer Biomet in Q2 2016 and has held it in 22 quarters since.
  • Regent Investment Management's Zimmer Biomet position peaked at $289K in Q2 2021.
  • 977 funds tracked by Wall St. Rank held Zimmer Biomet as of Q4 2022.

Based on Regent Investment Management's 13F filing for Q4 2022, filed 26 Jan 2023.